Cristina Gardelli
AstraZeneca (Australia)(AU)AstraZeneca (Switzerland)(CH)Institute of Immunology(HR)Respiratory Clinical Trials(AU)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Hepatitis C virus research, Cancer Immunotherapy and Biomarkers, Immune cells in cancer
Most-Cited Works
- → Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection(2008)627 cited
- → 4,5-Dihydroxypyrimidine Carboxamides and N-Alkyl-5-hydroxypyrimidinone Carboxamides Are Potent, Selective HIV Integrase Inhibitors with Good Pharmacokinetic Profiles in Preclinical Species(2006)99 cited
- → Enantioselective Total Synthesis of the Antitumor Macrolide Rhizoxin D(2003)89 cited
- → Dihydroxypyrimidine-4-carboxamides as Novel Potent and Selective HIV Integrase Inhibitors(2007)76 cited
- → Discovery and Synthesis of HIV Integrase Inhibitors: Development of Potent and Orally Bioavailable N-Methyl Pyrimidones(2007)67 cited
- → Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection(2009)54 cited